Cargando…
MAP3K1 rs889312 genotypes influence survival outcomes of Chinese gastric cancer patients who received adjuvant chemotherapy based on platinum and fluorouracil regimes
BACKGROUND: For patients with gastric cancer (GC), adjuvant chemotherapy is a standard therapy. However, the responses to the treatment are quite different. Mitogen-activated protein kinase (MAPK) pathway is a core pathway that modulates the efficacy of anticancer drugs. The purpose of our study was...
Autores principales: | Yang, Jian, Zheng, Wei, Xu, Zhi, Chen, Jinfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709816/ https://www.ncbi.nlm.nih.gov/pubmed/31686841 http://dx.doi.org/10.2147/OTT.S205438 |
Ejemplares similares
-
MAP3K1
rs889312 polymorphism and cancer prognosis: A systematic review and meta‐analysis
por: Aziz, Md. Abdul, et al.
Publicado: (2022) -
Influence of Programmed Death Ligand-1-Gene Polymorphism rs822336 on the Prognosis and Safety of Postoperative Patients with NSCLC Who Received Platinum-Based Adjuvant Chemotherapy
por: Zhao, Ming, et al.
Publicado: (2020) -
Influence of TS (rs34743033) and RUNX1 (rs2014300) gene polymorphisms on survival outcomes of fluorouracil-based chemotherapy in Chinese advanced gastric cancer patients
por: Han, Rongbo, et al.
Publicado: (2018) -
Metabolic tumor burden predicts prognosis of ovarian cancer patients who receive platinum‐based adjuvant chemotherapy
por: Yamamoto, Makoto, et al.
Publicado: (2016) -
The effects of genomic polymorphisms in one-carbon metabolism pathways on survival of gastric cancer patients received fluorouracil-based adjuvant therapy
por: Zhao, Tingting, et al.
Publicado: (2016)